Managing open innovation in biotechnology

TJ Fetterhoff, D Voelkel - Research-technology management, 2006 - Taylor & Francis
OVERVIEW: In the increasingly competitive landscape, there is a growing demand for
companies to be innovative. However, the concept of innovation is confounded by the …

The bioscience sector: challenges and opportunities

M O'Neill, M Hopkins - A Biotech Manager's Handbook, 2012 - Elsevier
Initially a term used to describe an emerging set of technologies,'biotech'has become
shorthand for a large part of the life science industry, a distinct sub-sector of smaller …

[引用][C] Technology Strategy Center (TSC) Activities in the Bioeconomy Field

T Kato - 2019 - TSC, NEDO, https://www. nedo. go …

Technological convergence throughout the eras: Part 3–Biotechnology

M Bernabo, I Garcia‐Bassets, L Gaines… - Business Strategy …, 2008 - emerald.com
Purpose–It is widely acknowledged that the pace of change due to complexity in the
competitive environment coupled with advances in technology and innovation is forcing …

Evolution of the Screening Metaphor: Project, Product, or Platform?

AA Boni - Journal of Commercial Biotechnology, 2019 - search.ebscohost.com
There are multiple options or paths to the market to be considered when developing the
commercialization strategy for translating a technology or invention into an innovation. We …

Adapting the roadmapping approach to science-intensive organizations: Lessons from a drug development program for neglected diseases

JS Freitas, RB Bagno, CM Bertollo… - Journal of Engineering …, 2019 - Elsevier
This paper discusses a roadmapping approach (RMA) adopted on a program on drug
discovery and development for neglected diseases. This experience led to changes in …

Converting biotech scientists to managers

DG Jensen, E Dougherty - Bioentrepreneur, 2004 - nature.com
Converting biotech scientists to managers | Bioentrepreneur Skip to main content Thank you
for visiting nature.com. You are using a browser version with limited support for CSS. To …

Biotechnology, a strategic planning orphan: towards an effective strategy framework for biotechnology firms

PL Molloy, LW Johnson - Journal of Commercial …, 2016 - search.proquest.com
Drug development biotechnology firms are most appropriately conceptualized as
intermediaries in the pharmaceutical R&D value chain. Because they generally do not …

Introductory Overview to Special Edition-" Building and Leveraging the Innovation Ecosystem and Clusters: Universities, Startups, Accelerators, Alliances, and …

AA Boni, M Gunn - Journal of Commercial Biotechnology, 2021 - search.ebscohost.com
This article focuses on the concepts of ecosystems and clusters, with an emphasis on their
importance for building vibrant a vibrant and life science/biopharma industry. We illustrate …

Strategic thinking about disruptive technologies

N Evans, B Ralston, A Broderick - Strategy & Leadership, 2009 - emerald.com
Purpose–A company's strategy work is not complete without a consideration of the ongoing
emergence of disruptive technologies from laboratories around the globe. This paper aims …